On November 25, 2025 AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, reported that Daniel Faga, president and chief executive officer of Anaptys, and/or other members of its executive leadership team, are scheduled to participate in multiple upcoming investor conferences:
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Piper Sandler 37th Annual Healthcare Conference, New York, NY
Format – Fireside chat and 1×1 investor meetings
Date and Time – Tuesday, Dec. 2, 2025 at 1:30pm ET
Evercore 8th Annual Healthcare Conference, Coral Gables, FL
Format – Fireside chat and 1×1 investor meetings
Date and Time – Wednesday, Dec. 3, 2025 at 7:55am ET
Live webcasts of the fireside chats will be available on the investor section of the Anaptys website at View Source Replays of the webcasts will be available for at least 30 days following the events.
(Press release, AnaptysBio, NOV 25, 2025, View Source [SID1234660941])